moxonidine has been researched along with Hypertension, Malignant in 1 studies
moxonidine: structure given in first source
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Moxonidine is well tolerated; its bioavailability after oral intake reaches 90%." | 2.47 | [Analysis of efficacy and safety of administration of moxonidine in patients with arterial hypertension and hypertensive crises]. ( Abdrakhmanov, VR; Baratashvili, VL; Gaponova, NI; Tereshchenko, SN, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaponova, NI | 1 |
| Abdrakhmanov, VR | 1 |
| Baratashvili, VL | 1 |
| Tereshchenko, SN | 1 |
1 review available for moxonidine and Hypertension, Malignant
| Article | Year |
|---|---|
[Analysis of efficacy and safety of administration of moxonidine in patients with arterial hypertension and hypertensive crises].
Topics: Administration, Oral; Antihypertensive Agents; Biological Availability; Blood Pressure; Humans; Hype | 2011 |